Hepion Pharmaceuticals, Inc. (HEPA) › Net IncomeHepion Pharmaceuticals, Inc. (HEPA) — Net IncomeAnnual figures by fiscal year, from SEC filings.2014: -$5.28M2015: -$14.35M2016: -$17.00M2017: -$14.89M2018: -$9.45M2019: -$7.04M2020: -$20.35M2021: -$32.72M2022: -$42.20M2023: -$48.93M2024: -$13.19M2025: -$8.28M-$8.28M2014Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025-$8.28M+37.3%2024-$13.19M+73.0%2023-$48.93M-15.9%2022-$42.20M-29.0%2021-$32.72M-60.8%2020-$20.35M-189.2%2019-$7.04M+25.5%2018-$9.45M+36.5%2017-$14.89M+12.4%2016-$17.00M-18.5%2015-$14.35M-171.7%2014-$5.28M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share